Also Included In: Diabetes; Cardiovascular / Cardiology
Article Date: 08 Dec 2011 - 0:00 PST
email to a friend
printer friendly
opinions 

Like Yin and Yang, the two proteins have opposite effects in the walls of blood vessels. AIF-1 stimulates undesirable formation of new cells after a vascular injury, and IRT-1 has the opposite effect. It is the latter, IRT-1, that Maria Gomez wants to use to stop a dangerous development in the artery, together with researchers at Lund University Diabetes Centre in Sweden and Temple University in the USA. They have already had success in animal experiments.
"After an arterial injury, the inner layer of cells in the artery begins to regrow. In the long term, this usually causes more harm than good", says Maria Gomez. A common cause of arterial injuries is the clearing of blocked arteries often performed on patients who have had a heart attack. "Initially the artery is opened up, but after a while new cell formation increases the risk of further heart attacks."
In animal experiments, the research groups have demonstrated the opposite effects of the two proteins. The carotid artery of rats was damaged with balloon dilation, simulating the procedure carried out on heart attack patients. After two weeks, there was noticeably less new cell formation in the arteries that had more of the protein IRT-1. With AIF-1, the opposite effect was observed.
"The interesting thing is that both proteins are formed from the same gene and we have now found a mechanism to control the balance in the formation of the two. Using a new drug we can thus increase the amount of the 'good' protein, IRT-1. It is not an approved drug, but it has been tested on mice and appears to be tolerated well", says Maria Gomez.
The researchers have also analysed over 150 fatty deposits ('plaques') removed from the carotid arteries of patients.
"We saw that the dangerous plaques - those that are unstable, easily rupture, are more inflamed and more often produce symptoms - contain more AIF-1. Those with a higher proportion of the protein IRT-1 are less dangerous", observes Lisa Berglund, co-author of the published study.
Diabetes patients develop more plaques, and more often dangerous ones, than non-diabetics. Diabetics have a significantly higher risk of suffering a heart attack.
The regrowth of cells in the arteries also leads to negative changes in blood flow. It may even be the case that AIF-1 is involved in the actual formation of plaques in the arteries.
Heart attacks are the most common cause of death in Sweden and many patients have repeated attacks, which are treated by clearing constrictions in the arteries of the heart using various methods. "If we could reduce the risk of repeat attacks, this would represent very significant progress", says Maria Gomez.
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.Visit our heart disease section for the latest news on this subject. The study has been published in the scientific journal Cardiovascular Research.
Link to a summary
NFAT regulates the expression of AIF-1 and IRT-1: Yin and yang splice variants of neointima formation and atherosclerosis
http://cardiovascres.oxfordjournals.org/content/early/2011/11/23/cvr.cvr309.abstract
Lund University Please use one of the following formats to cite this article in your essay, paper or report:
MLA
8 Dec. 2011.
Please note: If no author information is provided, the source is cited instead.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.